1Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia, Northern Cyprus.
Department of Infectious Diseases, Dr. Burhan Nalbantoglu State Hospital, Nicosia, Northern Cyprus.
Antimicrob Resist Infect Control. 2019 Jun 10;8:98. doi: 10.1186/s13756-019-0548-9. eCollection 2019.
Antibiotic-resistant in the gastrointestinal flora can lead to infections with limited therapeutic options. Also, the resistant bacteria can be transferred from colonized persons to others. The present study was conducted to search the fecal carriage rates of (i) that produce extended-spectrum β-lactamase (ESBL-E) and/or (ii) plasmid-mediated AmpC β-lactamase (pAmpC-E), (iii) ciprofloxacin-resistant (CIP-RE), and (iv) carbapenem-intermediate or -resistant (CIRE) in Northern Cyprus.
A total of 500 community-dwellers were recruited from consecutive admissions to the clinical laboratories of four hospitals. One rectal swab or stool sample was collected from each participant. A questionnaire was applied to evaluate possible risk factors associated with intestinal colonization of resistant bacteria. The samples were cultured on antibiotic containing media to screen for resistant bacteria colonization. The bacterial colonies that grew on the plates were subjected to further phenotypic tests to confirm the resistance.
Of 500 volunteers, ESBL-E, pAmpC-E, CIP-RE and CIRE carriage were detected in 107 (21.4%), 15 (3.0%), 51 (10.2%) and six (1.2%) participants, respectively. was the most commonly recovered species among isolates. A significant proportion of ESBL-producing isolates ( = 22/107; 20.6%) was found to be co-resistant to CIP ( = 0.000, OR 3.21, 95% CI 1.76-5.87). In this study, higher socioeconomic status (CIP-RE: = 0.024, OR 1.96, 95% CI 1.09-3.53), presence of gastrointestinal symptoms (CIRE: = 0.033; OR 6.79, 95% CI 1.34-34.39), antibiotic use (ESBL-E: = 0.031; OR 1.67, 95% CI 1.04-2.67; and CIRE: = 0.033; OR 6.40, 95% CI 1.16-35.39), and travelling abroad (pAmpC-E: = 0.010; OR 4.12, 95% CI 1.45-11.66) were indentified as risk factors.
The study indicates that resistant isolates are carried by humans in the community. To prevent further spread of resistance, rational use of antibiotics should be encouraged, and antibiotic resistance should be carefully monitored in Northern Cyprus.
胃肠道菌群中抗生素耐药性可导致治疗选择有限的感染。此外,耐药菌可从定植者传播给其他人。本研究旨在北塞浦路斯搜索(i)产生超广谱β-内酰胺酶(ESBL-E)和/或(ii)质粒介导的AmpC β-内酰胺酶(pAmpC-E)、(iii)环丙沙星耐药(CIP-RE)和(iv)碳青霉烯中介或耐药(CIRE)的粪便携带率。
从四家医院临床实验室连续入院的 500 名社区居民中招募了 500 名志愿者。从每位参与者中采集一个直肠拭子或粪便样本。应用问卷评估与肠道耐药菌定植相关的可能危险因素。将样本接种于含抗生素的培养基上,以筛选耐药菌定植。在平板上生长的细菌菌落进行进一步的表型试验以确认耐药性。
在 500 名志愿者中,107 名(21.4%)、15 名(3.0%)、51 名(10.2%)和 6 名(1.2%)参与者分别检测到 ESBL-E、pAmpC-E、CIP-RE 和 CIRE 携带。在分离的菌株中, 是最常见的恢复物种。发现相当比例的产 ESBL 株(=22/107;20.6%)对 CIP 具有共同耐药性(=0.000,OR 3.21,95%CI 1.76-5.87)。在这项研究中,较高的社会经济地位(CIP-RE:=0.024,OR 1.96,95%CI 1.09-3.53)、胃肠道症状(CIRE:=0.033;OR 6.79,95%CI 1.34-34.39)、抗生素使用(ESBL-E:=0.031;OR 1.67,95%CI 1.04-2.67;和 CIRE:=0.033;OR 6.40,95%CI 1.16-35.39)和出国旅行(pAmpC-E:=0.010;OR 4.12,95%CI 1.45-11.66)被确定为危险因素。
该研究表明,社区人群中携带耐药 。为防止耐药性进一步传播,应鼓励合理使用抗生素,并在北塞浦路斯仔细监测抗生素耐药性。